0 items USD 0.00Search
- Did you mean
- human epidemic
Your search for "Human Epidermal" gave back 12632 results.
The global Toxic Epidermal Neurolysis Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
March 2023
Price: USD 4,480.00
Epidermal care devices are adopted for ridding away the skin of dead cells. According to our Publisher latest study, the global Epidermal Care...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Toxic epidermal neurolysis, or TEN syndromes, are rare, severe forms of Stevens-Johnson syndrome (SJS). SJS only causes skin to blister and peel on...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Toxic epidermal neurolysis, or TEN syndromes, are rare, severe forms of Stevens-Johnson syndrome (SJS). SJS only causes skin to blister and peel on...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor. The global Trastuzumab...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Epidermal Growth Factor (EGF) Antibody is an unconjugated antibody to Epidermal Growth Factor (EGF). Highlights The global Epidermal Growth Factor (...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Toxic epidermal necrolysis (TEN) is a rare and serious skin condition. Often, it’s caused by an adverse reaction to medication like anticonvulsants...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages,...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market is accounted for $1.91 billion in 2017 and is expected to reach $4.96 billion by...
Catalog:
Stratistics MRC
June 2019
Price: USD 4,150.00
Summary Epidermal Growth Factor (EGF) (CAS 62253-63-8) market research report provides the newest industry data and industry future trends, allowing...
Catalog:
ICRW
December 2020
Price: USD 2,960.00
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Human Skin Model market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of...
Catalog:
GIR
December 2023
Price: USD 3,480.00
Epidermal Growth Factor Receptor (EC 2.7.10.1) - Drugs in Development, 2021 Summary Epidermal Growth Factor Receptor (EC 2.7.10.1) - Drugs in...
Catalog:
Global Markets Direct
April 2021
Price: USD 3,000.00
Epidermal Growth Factor (EGF) - Drugs in Development, 2021 Summary Epidermal Growth Factor (EGF) - Drugs in Development, 2021 provides in depth...
Catalog:
Global Markets Direct
April 2021
Price: USD 3,000.00
Epidermal Growth Factor (EGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,500.00
